Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-27 Sale | 2023-11-29 5:07 pm | eFFECTOR Therapeutics Inc. | EFTR | SR ONE CAPITAL MANAGEMENT LLC SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR One Co-Invest I LLC SR One Co-Invest I Manager LLC George Simeon 10% Owner | 609,163 | $0.6065 | $369,457 | 1,821,415 (Indirect) | View |
| 2022-10-04 Purchase | 2022-10-06 08:30 am | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 346 | $0.57 | $197 | 178,415 (Indirect Direct) | View |
| 2022-09-26 Purchase | 2022-09-27 08:01 am | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 18,867 | $0.55 | $10,377 | 178,069 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-19 Option Award | 2024-02-21 5:39 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Loewy Caroline M Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:27 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Bhatt Elizabeth Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:25 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:22 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:20 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:15 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Gallagher Brian M. Jr. Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:02 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:00 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Warner Douglas J Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 4:56 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-16 5:30 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 5,979 | $0.4973 | 829,543 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-16 5:26 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 4,524 | $0.4973 | 43,271 (Direct) | View |
| 2023-09-09 Option Award | 2023-09-11 7:38 pm | N/A 2033-09-08 | eFFECTOR Therapeutics Inc. | EFTR | Loewy Caroline M Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-09-11 7:36 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Loewy Caroline M Director | 0 | $0 | 9,047 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-14 08:00 am | N/A 2023-12-16 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 33,799 | $0 | 823,564 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-14 08:00 am | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 33,799 | $0.52 | 823,564 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-22 8:16 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-22 8:14 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-22 8:12 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-22 8:10 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Gallagher Brian M. Jr. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-22 8:09 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-22 8:04 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Bhatt Elizabeth Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-16 08:03 am | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 6,401 | $0.459 | 789,765 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-16 08:01 am | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 4,863 | $0.459 | 38,747 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:18 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Gallagher Brian M. Jr. Director | 50,938 | $0 | 50,938 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:15 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 36,875 | $0 | 36,875 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:13 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Harrington-Smith Kristen Director | 28,125 | $0 | 28,125 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:10 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Klencke Barbara Director | 28,125 | $0 | 28,125 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:07 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 35,938 | $0 | 35,938 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:05 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Bhatt Elizabeth Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:10 pm | N/A 2033-01-16 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:07 pm | N/A 2033-01-16 | eFFECTOR Therapeutics Inc. | EFTR | Warner Douglas J Chief Medical Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:04 pm | N/A 2033-01-16 | eFFECTOR Therapeutics Inc. | EFTR | Gandhi Mayank Chief Business Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:02 pm | N/A 2033-01-16 | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-11-15 Option Award | 2022-11-16 6:30 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Byrnes Michael Chief Financial Officer | 4,651 | $0.4684 | 33,884 (Direct) | View |
| 2022-11-15 Option Award | 2022-11-16 6:27 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 6,047 | $0.4684 | 783,364 (Direct) | View |
| 2022-09-26 Option Award | 2022-09-28 4:47 pm | N/A 2032-09-25 | eFFECTOR Therapeutics Inc. | EFTR | Gandhi Mayank Chief Business Officer | 500,000 | $0 | 500,000 (Direct) | View |
Ownership | 2022-08-11 5:05 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 0 | $0 | 5,435,229 (Indirect) | View |